Clare Kahn

Insider Reports History

Location
Cambridge, MA
Signature
/s/ by David Tyronne Howton as attorney-in-fact for Clare Kahn
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Clare Kahn:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Solid Biosciences Inc. Director Common Stock 2.96K $15.8K $5.34 11 Mar 2025 Direct
Solid Biosciences Inc. Director Director Stock Option (Right to Buy) 77.5K 12 Jun 2025 Direct

Insider Reports Filed by Clare Kahn

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SLDB Solid Biosciences Inc. 12 Jun 2025 1 $0 4 Director 13 Jun 2025, 16:25
SLDB Solid Biosciences Inc. 11 Mar 2025 1 $9.92K 4 Director 13 Mar 2025, 16:05
SLDB Solid Biosciences Inc. 11 Jun 2024 1 $0 4 Director 13 Jun 2024, 16:06
SLDB Solid Biosciences Inc. 07 Jun 2024 1 $8.44K 4 Director 11 Jun 2024, 14:15
SLDB Solid Biosciences Inc. 06 Jun 2023 1 $0 4 Director 08 Jun 2023, 21:22
SLDB Solid Biosciences Inc. 13 Dec 2022 1 $0 4 Director 15 Dec 2022, 17:10
SLDB Solid Biosciences Inc. 07 Jun 2022 2 $0 4 Director 09 Jun 2022, 17:10